Magnetically addressable nanoparticle platform
ArthroTarget develops a magnetically addressable nanoparticle platform with the objective of enabling spatially targeted drug delivery. The focus lies on the systemic architecture as well as on the physically controlled addressability of drug carriers. These elements are jointly developed within an integrated platform architecture.
Core research areas include:
Nanocarrier principles for locally addressable drug delivery systems
External controllability through physical fields
Controlled release mechanisms as part of platform development
The presented content relates to ongoing research and development activities. It does not represent a clinically approved therapy; certain technical details are currently not publicly disclosed for intellectual property reasons.
